An open-label, one-sequence, multiple administration study for exploration of microRNA and metabolomics biomarkers to predict drug induced liver injury in healthy elderly Korean people.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
17
Seoul National University Bundang Hospital
Seoul, South Korea
Area Under Curve (AUC)
Time frame: up to 35 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.